Moricizine

DB00680ApprovedWithdrawnSmall moleculeAntiarrhythmic agents

Moricizine is an antiarrhythmic used to treat arrhythmias. An antiarrhythmia agent used primarily for ventricular rhythm disturbances.

Chemical structure of Moricizine
Mechanism
Curator reviewed
Primary indication
Used to treat irregular heartbeats (arrhythmias) and maintain a normal heart rate.Curator reviewed
Formula / weight
C22H25N3O4S · 427.517 g/mol (avg)
First approval
United States, 1990
Also known as
Ethmozin · Etmozin
Code names
EN-313 · G 214

Resolves to

Compound
UNII2GT1D0TMX1CAS31883-05-3ChEMBLCHEMBL1075ChEBI6997PubChem34633KEGGD05077
Clinical / RWD
RxNorm40169ATCC01BG01PharmGKBPA164747738
Structure
InChIKeyFUBVWMNBEHXPSU-UHFFFAOYSA-NSMILESCCOC(=O)NC1=CC2=C(SC3=CC=CC=C3N2C(=O)CCN2CCOCC2)C=C1
Targets
Q14524SCN5A

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,143Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Marketed productsAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 19 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Moricizine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In